世界における小児インターベンション心臓病（医療機械）市場動向及び予測（～2018）...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 19)
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Market Share Calculation
1.6.4 Key Data Points from Primary Sources
1.6.5 Key Data Points from Secondary Sources
1.6.6 Assumptions

2 Executive Summary (Page No. – 31)

3 Premium Insights (Page No. – 35)
3.1 Investment Trends
3.2 Technology Trends
3.3 Regulatory Environment
3.3.1 Regulatory Approval Procedures for Pediatric Cardiology Devices
3.3.1.1 510(K) Application
3.3.1.2 Premarket Approval (Pma) Application
3.3.1.3 Humanitarian Device Exemption (Hde) Application
3.3.2 Intellectual Property Protection and Patent Litigation
3.4 Reimbursement Scenario: Transcatheter Heart Valves
3.5 Porter’s Five Forces Analysis: Pediatric Interventional Cardiology Imaging Market
3.5.1 Threat of New Entrants
3.5.2 Bargaining Power of Suppliers
3.5.3 Bargaining Power of Buyers
3.5.4 Competitor Rivalry
3.5.5 Threat of Substitutes
3.6 Unmet Need
3.6.1 Pediatric-Specific Cardiac Devices
3.7 Winning Imperatives
3.7.1 Investments in R&D Activities
3.7.2 Acquisitions

4 Market Overview (Page No. – 49)
4.1 Market Dynamics
4.1.1 Market Drivers
4.1.1.1 Pediatric Interventional Cardiology Devices
4.1.1.1.1 Government Support, An Impetus for the Pediatric Interventional Cardiology Market
4.1.1.1.2 Awareness Programs and Conferences to Fuel the Market
4.1.1.1.3 Rising Incidences of Congenital Heart Defects(CHD)to Propel the Pediatric Interventional Cardiology Market
4.1.1.1.4 Technological Advancements to Open New Opportunities for Device Manufacturers
4.1.1.1.5 Advantages of Minimally Invasive Procedures Over Conventional Surgeries to Propel the Market Growth
4.1.1.2 Pediatric Cardiology Imaging
4.1.1.2.1 Fda’s Efforts to Bolster the Pediatric Cardiology Imaging Market
4.1.2 Market Restraints
4.1.2.1 Pediatric Interventional Cardiology Devices
4.1.2.1.1 Complex Regulatory Procedures
4.1.2.1.2 Varied Stringency of Regulatory Procedures Delays Product Launches
4.1.2.2 Pediatric Cardiology Imaging
4.1.2.2.1 Implementation of Excise Tax By the U.S. Government
4.1.3 Market Opportunities
4.1.3.1 Pediatric Interventional Cardiology Devices
4.1.3.1.1 Advances In Biodegradable Devices for Pediatric Cardiology
4.1.3.1.2 Asia-Pacific Region Presents Significant Growth Opportunities
4.1.3.1.3 Robust Growth in the Transcatheter Heart Valves Market
4.1.3.2 Pediatric Cardiology Imaging
4.1.3.2.1 Mobile Cath Labs, An Upcoming Opportunity Area
4.1.4 Challenges
4.1.4.1 Pediatric Interventional Cardiology Devices
4.1.4.1.1 Difficulties in Pediatric Clinical Trials
4.1.4.2 Pediatric Cardiology Imaging
4.1.4.2.1 High Cost of Pediatric Interventional Cardiology Imaging Devices
4.1.4.2.2 Survival of Small Players and New Entrants
4.2 Market Share Analysis
4.2.1 Structural Heart Defect Closure Devices
4.2.2 Transcatheter Heart Valves

5 Pediatric Interventional Cardiology Procedures (Page No. – 67)
5.1 Introduction
5.2 North America
5.3 Europe
5.4 APAC
5.5 ROW

6 Pediatric Interventional Cardiology Devices Market (Page No. – 77)
6.1 Introduction
6.2 Heart Defect Closure Devices
6.2.1 ASD, VSD, & PFO Closure Devices
6.2.1.1 Atrial Septal Defect (ASD) Closure Devices
6.2.1.2 Ventricular Septal Defect (VSD) Closure Devices
6.2.1.3 Patent Foramen Ovale (PFO) Closure Devices
6.2.2 Patent Ductus Arteriosus (Pda) Closure Devices
6.2.3 Left Atrial Appendage (Laa) Closure Devices
6.3 Transcatheter Heart Valves
6.3.1 Transcatheter Pulmonary Valves
6.3.2 Transcatheter Aortic Valves (TAV)
6.4 Others
6.4.1 Angioplasty Balloons
6.4.2 Angioplasty Stents
6.4.3 Catheters
6.4.4 Guidewires

7 Geographic Analysis (Page No. – 130)
7.1 Introduction
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 U.K.
7.2.4 Italy
7.2.5 Spain
7.2.6 Roe
7.3 North America
7.3.1 U.S.
7.3.2 Canada
7.4 Asia-Pacific (APAC)
7.5 Rest of the World (ROW)

8 Competitive Landscape (Page No. – 158)
8.1 Pediatric Interventional Cardiology Imaging Market
8.1.1 Introduction
8.1.2 New Product Launches
8.1.3 Acquisitions
8.1.4 Agreements
8.1.5 Expansions
8.1.6 Approvals
8.2 Pediatric Interventional Cardiology Devices Market
8.2.1 Introduction
8.2.2 Acquisitions
8.2.3 Agreements
8.2.4 New Product Launches
8.2.5 Other Developments
8.2.6 Approvals

9 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 176)
9.1 Imaging Products Companies
9.1.1 Ge Healthcare (Subsidiary of General Electric Company)
9.1.2 Siemens Healthcare (Subsidiary of Siemens AG)
9.1.3 toshiba Corporation
9.2 Pediatric Interventional Cardiology Device Companies
9.2.1 Edwards Lifesciences
9.2.2 Gore Medical (Subsidiary of W.L. Gore & Associates)
9.2.3 Medtronic, Inc.
9.2.4 St. Jude Medical
9.2.5 Abbott Vascular (A Subsidiary of Abbott Laboratories)
9.2.6 Boston Scientific Corporation
9.2.7 Cordis Corporation (Subsidiary of Johnson & Johnson)
9.2.8 Numed, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.